NCT00038220View on ClinicalTrials.gov

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2000

Conditions
HIV Infections
Interventions
DRUG

Lopinavir/ritonavir

DRUG

Efavirenz

DRUG

Lamivudine

DRUG

Tenofovir DF

Trial Locations (1)

10021

Aaron Diamond AIDS Research Center - Rockefeller University, New York

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY